Daptomycin versus Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection with or without Endocarditis: A Systematic Review and Meta-Analysis.
Alberto Enrico MaraoloAgnese GiacconeGentile IvanAnnalisa SaracinoDavide Fiore BavaroPublished in: Antibiotics (Basel, Switzerland) (2021)
Against MRSA BSI, with or without endocarditis, daptomycin seems to be associated with a lower risk of clinical failure and treatment-limiting AEs compared with vancomycin. Further studies are needed to better characterize the differences between the two drugs.